Issue Information
3 September 2019
Toward Elimination of Hepatitis C Infection: How Best to Address Gaps in the Cascade of Care?
Vijay Prabhakar, Paul Y. Kwo – 3 September 2019
R‐spondin 2 Drives Liver Tumor Development in a Yes‐Associated Protein‐Dependent Manner
Caitlin B. Conboy, Germán L. Vélez‐Reyes, Barbara R. Tschida, Hsiangyu Hu, Gabriel Kaufmann, Nicholas Koes, Bryant Keller, Clara Alsinet, Helena Cornellà, Roser Pinyol, Juan E. Abrahante, Nuri A. Temiz, Michael A. Linden, Khalid Amin, Timothy P. Kuka, Vincent W. Keng, Josep M. Llovet, Timothy K. Starr, David A. Largaespada – 3 September 2019 – Each year, more than 25,000 people succumb to liver cancer in the United States, and this neoplasm represents the second cause of cancer‐related death globally.
Electronic Consultations: Delivering Specialty Care Anywhere
Grace L. Su – 3 September 2019
Consult for Portal Vein Thrombosis
Thomas G. Cotter, Anjana A. Pillai – 2 September 2019
Hepatology Clearance for Immunomodulation in Patients With Hepatitis B
Tae Hoon Lee, Thomas D. Schiano – 2 September 2019
Mechanisms of Action of Drugs Effective in Hepatocellular Carcinoma
Samantha Sarcognato, Teresa García‐Lezana, Augusto Villanueva – 2 September 2019
CON: Patients of Advanced Age Should Not Routinely Undergo Liver Transplantation
Avash Kalra, Michael Kriss, Prashanth Francis, J. P. Norvell – 2 September 2019
Severe Acute Hepatitis Attributed to the Herbal and Dietary Supplement OxyELITE Pro
Robert J. Fontana – 2 September 2019
New Drugs Effective in the Systemic Treatment of Hepatocellular Carcinoma
Carla Montironi, Robert Montal, Josep M. Llovet – 2 September 2019